» Affymax and Takeda Announce Long-Term Hematide Safety and <b>...</b>
STOCKHOLM, Sweden—(BUSINESS WIRE)—May 12, 2008 - Takeda Global Research & Development Center, Inc. and Affymax, Inc. (Nasdaq:AFFY) today reported positive 12 month data from their ongoing Phase 2 …